SLU-PP-332 2mg — Vial Spec, Reconstitution Math & COA
This technical reference provides laboratory researchers with analytical specifications, precise solvent dilution math, aliquoting guidelines, and Certificate of Analysis (COA) verification protocols for the 2mg SLU-PP-332 vial format. All product specifications are strictly intended for in vitro assays, metabolic pathway analysis, and non-human animal research protocols.
Quick answer
This technical reference provides laboratory researchers with analytical specifications, precise solvent dilution math, aliquoting guidelines, and Certificate of Analysis (COA) verification protocols for the 2mg SLU-PP-332 vial format. All product specifications are strictly intended for in vitro assays, metabolic pathway analysis, and non-human animal research protocols.
Key takeaways
- A 2mg SLU-PP-332 research vial contains precisely 2.0 milligrams of high-purity, lyophilized synthetic SLU-PP-332 (C25H21F3N2O3, CAS 2919818-72-9).
- In preclinical investigations, SLU-PP-332 functions as a potent activator of the orphan nuclear receptor family composed of ERRα, ERRβ, and ERRγ.
- Achieving exact working concentrations requires strict volumetric calculations based on the total 2.0 mg target lyophilized mass.
- Multiple freeze-thaw cycles significantly accelerate the chemical degradation of small molecules in liquid solution.
What a 2mg SLU-PP-332 Research Vial Contains and Laboratory Utility
A 2mg SLU-PP-332 research vial contains precisely 2.0 milligrams of high-purity, lyophilized synthetic SLU-PP-332 (C25H21F3N2O3, CAS 2919818-72-9). SLU-PP-332 is a novel synthetic small molecule engineered as a selective pan-agonist of the Estrogen-Related Receptors (ERRα, ERRβ, and ERRγ). In laboratory settings, this specific 2mg mass allocation provides an ideal footprint for primary feasibility trials, micro-plate cell culture assays, and short-duration rodent exploratory models where minimizing compound wastage is paramount.
Principal investigators and research technicians typically select the 2mg unit size when designing small-cohort pilot studies or high-throughput in vitro screens. Because synthetic small molecules can undergo gradual chemical alteration or physical degradation once solubilized, a lower net vial mass ensures that reconstituted stock solutions are fully utilized within optimal stability windows. If your laboratory requires alternate delivery modalities or broader compound inventories, PX1 Research maintains a comprehensive selection across our all-peptides catalog, as well as specialized solid oral research formats such as SLU-PP-332 Capsules 250mcg.
Molecular Mechanism & Estrogen-Related Receptor (ERR) Agonism
In preclinical investigations, SLU-PP-332 functions as a potent activator of the orphan nuclear receptor family composed of ERRα, ERRβ, and ERRγ. These nuclear receptors regulate transcriptional networks responsible for mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and skeletal muscle fiber type switching. Preclinical rodent studies demonstrate that administration of ERR agonists leads to increased expression of ERR-target genes (such as Pgc-1α and Acadm), enhanced oxidative muscle capacity, and elevated basal metabolic energy expenditure without requiring physical exercise stimulus.
When designing comparative protocols evaluating metabolic endurance, mitochondrial mass, or energetic expenditure, researchers frequently compare SLU-PP-332 against other pathways and metabolic compounds. For example, investigators often benchmark ERR agonism alongside AMPK activators like 5-Amino-1MQ, Rev-ErbA agonists like SR9009, or mitochondrial-derived peptides like MOTS-c. Detailed background literature regarding these pathways can be explored in the PX1 research library.
Reconstitution Mathematics for 2mg Vials (1mL, 2mL, 3mL Solvents)
Achieving exact working concentrations requires strict volumetric calculations based on the total 2.0 mg target lyophilized mass. Depending on the solvent system selected (such as sterile DMSO, ethanol, or specialized aqueous buffers containing appropriate co-solvents), researchers must add exact volumes of diluent to establish target working concentrations.
Below are standard reconstitution metrics for a 2mg (2,000 µg) vial of SLU-PP-332: • 1.0 mL Diluent Added = 2.0 mg/mL final concentration (2,000 µg/mL or 2.0 µg/µL). • 2.0 mL Diluent Added = 1.0 mg/mL final concentration (1,000 µg/mL or 1.0 µg/µL). • 3.0 mL Diluent Added = 0.67 mg/mL final concentration (666.7 µg/mL or ~0.67 µg/µL). To eliminate manual conversion errors and configure custom volumetric concentrations for micro-pipetting, laboratory personnel are advised to utilize the interactive reconstitution calculator.
Aliquoting Strategies & Freeze-Thaw Degradation Prevention
Multiple freeze-thaw cycles significantly accelerate the chemical degradation of small molecules in liquid solution. To preserve structural integrity and maintain consistent bioactivity across sequential experimental trials, stock solutions prepared from a 2mg vial should be sub-aliquoted immediately following complete dissolution.
Working in a laminar flow hood, dispense the reconstituted SLU-PP-332 stock solution into single-use, sterile polypropylene microcentrifuge tubes (e.g., 50 µL to 200 µL aliquots). Flush the headspace of each aliquot container with inert argon or nitrogen gas prior to sealing, if available, to prevent atmospheric oxidation. Label each tube with the exact compound name, reconstitution date, lot number, and final working concentration, then transfer immediately to ultra-low temperature storage.
Storage Protocols & Stability Parameters
Lyophilized SLU-PP-332 in its original sealed glass vial must be stored at -20°C for standard short-to-medium duration storage, or at -80°C for long-term archival preservation. Shield the lyophilized powder from direct light and ambient moisture. Under these ultra-low temperature conditions, unopened lyophilized vials maintain chemical stability for up to 24 months from the manufacturing date.
Once reconstituted, liquid stock solutions stored in appropriate solvents (such as anhydrous DMSO) should be kept at -80°C and used within 3 to 6 months. Reconstituted aqueous mixtures held at standard refrigeration temperatures (2°C to 8°C) should be utilized within 24 to 48 hours to prevent hydrolysis or precipitation. Never subject reconstituted SLU-PP-332 stock to repeated thermal fluctuations.
Certificate of Analysis (COA) Architecture and Purity Verification
Every batch of SLU-PP-332 manufactured for PX1 Research undergoes stringent multi-stage analytical screening at independent ISO 17025 accredited laboratories. We do not rely on generic manufacturer declarations; every fill size and production lot is assigned a lot-matched Certificate of Analysis (COA).
The complete analytical testing suite includes High-Performance Liquid Chromatography (HPLC) to verify chemical purity exceeding 98.0%, Mass Spectrometry (MS) to confirm exact molecular weight and structural identity, Karl Fischer Titration to measure residual moisture, and Endotoxin Testing (LAL assay) to ensure compliance with strict preclinical research standards. Researchers can review or download batch-specific test documentation directly on our COA access page.
Selecting Vial Sizes: When 2mg vs. Larger or Alternate Formats Is Optimal
Selecting the correct unit format depends on experimental design, assay volume, and subject group size. A 2mg vial is the optimal baseline format for preliminary in vitro receptor binding assays, cell viability screens, or pilot rodent dosing studies where minimal solution volume is needed.
For high-throughput industrial screens, continuous daily dosing protocols in rodent cohorts, or institutional research requiring bulk master stocks, larger unit masses or bulk custom fills reduce unit handling steps and minimize per-milligram expenditure. Research facilities planning high-volume research regimens are encouraged to establish institutional accounts via our wholesale portal.
Quality Control & USA Manufacturing Standards at PX1 Research
PX1 Research synthesizes and packages all research compounds within cGMP-compliant facilities located in the United States. Our manufacturing process enforces strict environmental controls, cleanroom packaging, and zero-filler protocols to guarantee that every vial contains pure compound without undisclosed bulking agents or micro-contaminants.
Orders placed prior to daily cutoff times ship same-day (Monday through Friday) directly from our centralized distribution centers located in California and Arizona. Each package is thermal-insulated and securely sealed to protect temperature-sensitive compounds throughout transit.
Frequently Asked Questions
What is the certified chemical purity of PX1 Research SLU-PP-332 2mg vials?
PX1 Research guarantees that all SLU-PP-332 lots maintain a minimum purity of 98.0% as verified by independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).
How do I calculate microgram concentrations per microliter for a 2mg vial?
Dissolving 2mg (2,000 µg) of SLU-PP-332 in 1.0 mL of solvent yields 2.0 µg/µL (2,000 µg/mL). Dissolving in 2.0 mL yields 1.0 µg/µL (1,000 µg/mL).
Which solvents are recommended for reconstituting SLU-PP-332?
SLU-PP-332 is a hydrophobic small molecule that dissolves readily in dimethyl sulfoxide (DMSO) or ethanol. For cell culture or in vivo protocols, pre-dissolve in DMSO before diluting into an appropriate sterile aqueous buffer.
Where can I verify the lot-matched COA for my SLU-PP-332 shipment?
Lot-matched Certificates of Analysis containing full HPLC chromatograms and MS spectra can be downloaded directly from the PX1 Research COA portal at /coa.
What is the bacterial endotoxin specification for PX1 research compounds?
All PX1 Research compounds undergo LAL endotoxin testing to confirm levels remain strictly below standardized limits (<0.01 EU/µg) suitable for preclinical laboratory protocols.
How should reconstituted SLU-PP-332 stock solution be stored?
Reconstituted stock solution should be divided into single-use micro-aliquots and stored at -80°C. Protect the solution from light exposure and avoid repeated freeze-thaw cycles.
Is SLU-PP-332 approved for human consumption or clinical administration?
No. SLU-PP-332 is an unapproved investigational compound supplied strictly for in vitro laboratory research and non-human animal studies. Human or veterinary consumption is strictly prohibited.
Does PX1 offer bulk institutional procurement for SLU-PP-332?
Yes. Institutional accounts, academic labs, and corporate research organizations requiring larger quantities or specialized packaging can submit request details via our wholesale portal.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.